The critical role of comorbidities and polypharmacy in lower risk myelodysplastic patients: is there any difference between countries?

Saved in:
Bibliographic Details
Published inMedical oncology (Northwood, London, England) Vol. 35; no. 11; pp. 143 - 3
Main Authors Mendonça, Priscila da Silva, Feitosa, Ronald Pinheiro, Magalhães, Silvia Maria Meira
Format Journal Article
LanguageEnglish
Published New York Springer US 01.11.2018
Springer Nature B.V
Subjects
Hematology
Internal Medicine
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
Pathology
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1357-0560
1559-131X
DOI:10.1007/s12032-018-1205-5